Travelers: Truist Securities raises target price to $435 from $425
TRV•Truist Securities raised its target price for Travelers to $435 from $425.
Related News
Marker Therapeutics awarded $2.6 million FDA grant to advance MT-601 in pancreatic cancer
MRKR•
The GEO Group completes redemption of all senior secured notes due 2029
GEO•
Raymond James cuts Oceanagold target price to C$52 from C$53
OGC•
Freeport bets on chemical solution to reach copper leaching target
FCX•
Evercore names John Vaske senior managing director in chemicals investment banking
EVR•